Controversies in the follow-up and management of well-differentiated thyroid cancer

M. D. Ringel, P. W. Ladenson

Research output: Contribution to journalReview article

Abstract

Thyroid cancer is a common malignancy with an apparent increasing incidence and a wide spectrum of clinical behavior and therapeutic responsiveness. Recent advances in diagnosis, primary treatment, and long-term monitoring have led to enhanced detection of primary and recurrent disease and improvements in therapy. Controversy still surrounds several issues: the most accurate predictive staging system and histological subclassification scheme, optimal preoperative assessment and surgical extent, appropriate use of radioiodine for remnant ablation, goal for thyrotropin-suppressive thyroid hormone therapy, best practices in immediate postoperative and long-term monitoring, and approach to the patient with thyroglobulin evidence of residual disease. In this paper, recent data related to these controversial issues are critically reviewed.

Original languageEnglish (US)
Pages (from-to)97-116
Number of pages20
JournalEndocrine-related cancer
Volume11
Issue number1
DOIs
StatePublished - Mar 1 2004

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Endocrinology
  • Cancer Research

Fingerprint Dive into the research topics of 'Controversies in the follow-up and management of well-differentiated thyroid cancer'. Together they form a unique fingerprint.

  • Cite this